{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:09:44Z","timestamp":1791216584717,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.nbd.2014.04.016","type":"journal-article","created":{"date-parts":[[2014,5,4]],"date-time":"2014-05-04T20:15:50Z","timestamp":1399234550000},"page":"65-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":125,"special_numbering":"C","title":["Excitation\/inhibition balance and learning are modified by Dyrk1a gene dosage"],"prefix":"10.1016","volume":"69","author":[{"given":"Benoit","family":"Souchet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fay\u00e7al","family":"Guedj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignasi","family":"Sah\u00fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Duchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Daubigney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Badel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchio","family":"Yanagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jose","family":"Barallobre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Dierssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Herault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariona","family":"Arbones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Janel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Cr\u00e9au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Maurice","family":"Delabar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2014.04.016_bb0005","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.nbd.2005.12.006","article-title":"DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects","volume":"22","author":"Ahn","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.04.016_bb0010","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/hmg\/10.18.1915","article-title":"Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome","volume":"10","author":"Altafaj","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2014.04.016_bb0015","doi-asserted-by":"crossref","first-page":"e2575","DOI":"10.1371\/journal.pone.0002575","article-title":"Impaired spatial learning strategies and novel object recognition in mice haploinsufficient for the dual specificity tyrosine-regulated kinase-1A (Dyrk1A)","volume":"3","author":"Arque","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2014.04.016_bb0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fncel.2011.00029","article-title":"Environmental enrichment decreases GABAergic inhibition and improves cognitive abilities, synaptic plasticity, and visual functions in a mouse model of Down syndrome","volume":"5","author":"Begenisic","year":"2011","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2014.04.016_bb0025","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1523\/JNEUROSCI.1547-09.2009","article-title":"The \u201cDown syndrome critical region\u201d is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome","volume":"29","author":"Belichenko","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.04.016_bb0030","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/cne.21895","article-title":"Excitatory-inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of Down syndrome","volume":"512","author":"Belichenko","year":"2009","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2014.04.016_bb0035","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.expneurol.2011.11.033","article-title":"Dysfunctional hippocampal inhibition in the Ts65Dn mouse model of Down syndrome","volume":"233","author":"Best","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2014.04.016_bb0040","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1177\/0269881111405366","article-title":"Specific targeting of the GABA-A receptor alpha5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice","volume":"25","author":"Braudeau","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.nbd.2014.04.016_bb0045","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nn.2600","article-title":"Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome","volume":"13","author":"Chakrabarti","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2014.04.016_bb0050","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1038\/sj.npp.1301535","article-title":"Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test","volume":"33","author":"Costa","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2014.04.016_bb0055","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/jmedgenet-2012-101251","article-title":"The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy","volume":"49","author":"Courcet","year":"2012","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.nbd.2014.04.016_bb0060","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1054-3589(10)58015-3","article-title":"GABAB-GIRK2-mediated signaling in Down syndrome","volume":"58","author":"Cramer","year":"2010","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.nbd.2014.04.016_bb0065","doi-asserted-by":"crossref","first-page":"171639","DOI":"10.1155\/2012\/171639","article-title":"Molecular and cellular alterations in Down syndrome: toward the identification of targets for therapeutics","volume":"2012","author":"Cr\u00e9au","year":"2012","journal-title":"Neural Plast."},{"key":"10.1016\/j.nbd.2014.04.016_bb0070","first-page":"117","article-title":"Segmental trisomy as a mouse model for Down syndrome","volume":"384","author":"Davisson","year":"1993","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.nbd.2014.04.016_bb0075","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/mnfr.201300325","article-title":"Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans","volume":"58","author":"De la Torre","year":"2014","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.nbd.2014.04.016_bb0080","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000472398","article-title":"Molecular mapping of twenty-four features of Down syndrome on chromosome 21","volume":"1","author":"Delabar","year":"1993","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2014.04.016_bb0085","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neulet.2006.11.026","article-title":"Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome","volume":"413","author":"Dowjat","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2014.04.016_bb0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0304-3940(95)12052-6","article-title":"A behavioral assessment of Ts65Dn mice: a putative Down syndrome model","volume":"199","author":"Escorihuela","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2014.04.016_bb0095","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.nbd.2011.04.011","article-title":"Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of beta1-adrenergic receptor by xamoterol as a potential cognitive enhancer","volume":"43","author":"Faizi","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.04.016_bb0100","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nn1860","article-title":"Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome","volume":"10","author":"Fernandez","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2014.04.016_bb0105","doi-asserted-by":"crossref","first-page":"6636","DOI":"10.1128\/MCB.22.18.6636-6647.2002","article-title":"Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice","volume":"22","author":"Fotaki","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2014.04.016_bb0115","doi-asserted-by":"crossref","first-page":"e4606","DOI":"10.1371\/journal.pone.0004606","article-title":"Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A","volume":"4","author":"Guedj","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2014.04.016_bb0110","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2012.01.007","article-title":"DYRK1A: a master regulatory protein controlling brain growth","volume":"46","author":"Guedj","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.04.016_bb0120","doi-asserted-by":"crossref","first-page":"467251","DOI":"10.1155\/2012\/467251","article-title":"Adult-onset fluoxetine treatment does not improve behavioral impairments and may have adverse effects on the Ts65Dn mouse model of Down syndrome","volume":"2012","author":"Heinen","year":"2012","journal-title":"Neural Plast."},{"key":"10.1016\/j.nbd.2014.04.016_bb0125","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuint.2006.07.004","article-title":"Mapping convulsants' binding to the GABA-A receptor chloride ionophore: a proposed model for channel binding sites","volume":"50","author":"Kalueff","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2014.04.016_bb0140","doi-asserted-by":"crossref","first-page":"8153","DOI":"10.1523\/JNEUROSCI.1766-04.2004","article-title":"Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome","volume":"24","author":"Kleschevnikov","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.04.016_bb0130","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1523\/JNEUROSCI.1673-12.2012","article-title":"Deficits in cognition and synaptic plasticity in a mouse model of Down syndrome ameliorated by GABAB receptor antagonists","volume":"32","author":"Kleschevnikov","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.04.016_bb0135","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.nbd.2011.10.009","article-title":"Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome","volume":"45","author":"Kleschevnikov","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.04.016_bb0145","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tins.2013.11.005","article-title":"A de novo convergence of autism genetics and molecular neuroscience","volume":"37","author":"Krumm","year":"2014","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2014.04.016_bb0150","doi-asserted-by":"crossref","first-page":"8521","DOI":"10.1523\/JNEUROSCI.1245-12.2012","article-title":"Activity-dependent regulation of inhibition via GAD67","volume":"32","author":"Lau","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.04.016_bb0155","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/hmg\/ddm086","article-title":"Duplication of the entire 22.9Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities","volume":"16","author":"Li","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2014.04.016_bb0160","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.bbr.2010.03.036","article-title":"Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome","volume":"221","author":"Lockrow","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2014.04.016_bb0165","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1523\/JNEUROSCI.1203-12.2013","article-title":"Reducing GABAA alpha5 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of Down syndrome","volume":"33","author":"Martinez-Cue","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.04.016_bb0170","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0091-3057(01)00466-X","article-title":"Sex differences in sensitivity to seizures elicited by pentylenetetrazol in mice","volume":"68","author":"Medina","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.nbd.2014.04.016_bb0175","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.bcp.2012.06.028","article-title":"Cognitive enhancement by pharmacological and behavioral interventions: the murine Down syndrome model","volume":"84","author":"M\u00f6hler","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.nbd.2014.04.016_bb0180","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.ajhg.2008.03.001","article-title":"Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly","volume":"82","author":"Moller","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2014.04.016_bb0190","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000320113","article-title":"Distinctive phenotypic abnormalities associated with submicroscopic 21q22 deletion including DYRK1A","volume":"1","author":"Oegema","year":"2010","journal-title":"Mol. Syndromol."},{"key":"10.1016\/j.nbd.2014.04.016_bb0195","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/hmg\/ddm022","article-title":"Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice","volume":"16","author":"Olson","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2014.04.016_bb0185","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1126\/science.1227764","article-title":"Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders","volume":"338","author":"O'Roak","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.nbd.2014.04.016_bb0200","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00702-010-0376-9","article-title":"Alteration of inhibitory circuits in the somatosensory cortex of Ts65Dn mice, a model for Down's syndrome","volume":"117","author":"Perez-Cremades","year":"2010","journal-title":"J. Neural Transm."},{"issue":"1","key":"10.1016\/j.nbd.2014.04.016_bb0205","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/18715273113126660185","article-title":"Reducing GABAergic inhibition restores cognitive functions in a mouse model of Down syndrome","volume":"13","author":"Potier","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.nbd.2014.04.016_bb0210","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.1073\/pnas.86.15.5958","article-title":"Critical role of the D21S55 region on chromosome 21 in the pathogenesis of Down syndrome","volume":"86","author":"Rahmani","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.04.016_bb0215","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ng1095-177","article-title":"A mouse model for Down syndrome exhibits learning and behaviour deficits","volume":"11","author":"Reeves","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2014.04.016_bb0220","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00335-011-9357-z","article-title":"Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn","volume":"22","author":"Reinholdt","year":"2011","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.nbd.2014.04.016_bb0225","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0304-3940(01)01885-7","article-title":"SHIRPA, a protocol for behavioral assessment: validation for longitudinal study of neurological dysfunction in mice","volume":"306","author":"Rogers","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2014.04.016_bb0230","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/jmg.2006.047373","article-title":"Familial 4.3Mb duplication of 21q22 sheds new light on the Down syndrome critical region","volume":"44","author":"Ronan","year":"2007","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.nbd.2014.04.016_bb0235","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1034\/j.1601-183X.2003.00037.x","article-title":"Model of autism: increased ratio of excitation\/inhibition in key neural systems","volume":"2","author":"Rubenstein","year":"2003","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.nbd.2014.04.016_bb0240","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3233\/JAD-2010-100240","article-title":"Memantine normalizes several phenotypic features in the Ts65Dn mouse model of Down syndrome","volume":"21","author":"Rueda","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2014.04.016_bb0245","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1523\/JNEUROSCI.6412-11.2012","article-title":"The fraction of cortical GABAergic neurons is constant from near the start of cortical neurogenesis to adulthood","volume":"32","author":"Sahara","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.04.016_bb0250","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0028-3908(97)00157-3","article-title":"Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down Syndrome","volume":"36","author":"Siarey","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2014.04.016_bb0255","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1601-183X.2008.00428.x","article-title":"Molecular responses of the Ts65Dn and Ts1Cje mouse models of Down syndrome to MK-801","volume":"7","author":"Siddiqui","year":"2008","journal-title":"Genes Brain Behav."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2014.04.016_bb0260","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/S0387-7604(03)90012-X","article-title":"Neurobiology of Tourette's syndrome: concepts of neuroanatomic localization and neurochemical abnormalities","volume":"25","author":"Singer","year":"2003","journal-title":"Brain Dev."},{"key":"10.1016\/j.nbd.2014.04.016_bb0265","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ng0597-28","article-title":"Functional screening of 2Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome","volume":"16","author":"Smith","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2014.04.016_bb0270","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1523\/JNEUROSCI.5616-10.2011","article-title":"PSD-95 and PSD-93 play critical but distinct roles in synaptic scaling up and down","volume":"31","author":"Sun","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.04.016_bb0275","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/cne.10905","article-title":"Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse","volume":"467","author":"Tamamaki","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2014.04.016_bb0280","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0896-6273(95)90286-4","article-title":"minibrain: a new protein kinase family involved in postembryonic neurogenesis in Drosophila","volume":"14","author":"Tejedor","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.04.016_bb0285","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1523\/JNEUROSCI.2852-13.2014","article-title":"Prefrontal deficits in a murine model overexpressing the down syndrome candidate gene dyrk1a","volume":"34","author":"Thomazeau","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.04.016_bb0290","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00221-009-2059-z","article-title":"Postnatal exposure to MK801 induces selective changes in GAD67 or parvalbumin","volume":"201","author":"Turner","year":"2010","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.nbd.2014.04.016_bb0295","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1399-0004.2010.01544.x","article-title":"Intragenic deletion in DYRK1A leads to mental retardation and primary microcephaly","volume":"79","author":"van Bon","year":"2011","journal-title":"Clin. Genet."},{"key":"10.1016\/j.nbd.2014.04.016_bb0300","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuroscience.2012.06.031","article-title":"Lack of behavioral and cognitive effects of chronic ethosuximide and gabapentin treatment in the Ts65Dn mouse model of Down syndrome","volume":"220","author":"Vidal","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.04.016_bb0305","doi-asserted-by":"crossref","first-page":"9415","DOI":"10.1073\/pnas.0803756105","article-title":"Synaptojanin 1-linked phosphoinositide dyshomeostasis and cognitive deficits in mouse models of Down's syndrome","volume":"105","author":"Voronov","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.04.016_bb0310","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.jcp.0000095349.32154.a5","article-title":"GABA and schizophrenia: a review of basic science and clinical studies","volume":"23","author":"Wassef","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.nbd.2014.04.016_bb0315","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.brainres.2010.09.107","article-title":"Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice","volume":"1366","author":"Yu","year":"2010","journal-title":"Brain Res."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114001053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114001053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T17:50:17Z","timestamp":1772473817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996114001053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":63,"alternative-id":["S0969996114001053"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2014.04.016","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Excitation\/inhibition balance and learning are modified by Dyrk1a gene dosage","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2014.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}